Strain Echocardiography Predicts Hypertrophic Cardiomyopathy Risk
By MedImaging International staff writers Posted on 30 Jun 2016 |
Image: Researchers found using strain echocardiography could accurately predict which patients were likely to have complications from hypertrophic cardiomyopathy (Photo courtesy of GE / JHU).
A new study shows that strain echocardiography can accurately predict which patients are likely to have complications resulting from hypertrophic cardiomyopathy (HCM).
Researchers at Johns Hopkins University (JHU, Baltimore, MD, USA) conducted a study in 400 HCM patients who were followed for 37 months, and who underwent both conventional and strain echocardiography to obtain global longitudinal strain (GLS) data, an objective and reproducible imaging modality than can be used to quantify subtle disturbances in left ventricular (LV) function by detecting sub-endocardial contractility and viability, which often precede an overt impairment of LV function, as measured by ejection fraction (EF).
The results showed that GLS measured by strain echocardiography can be used as a cardiovascular diagnostic technique that is a sensitive and powerful way to assess patient HCM outcomes, which are a common, but often undetected, leading cause of sudden cardiac death (SCD) in young adults. The study was presented as a poster session at the American Society of Echocardiography (ASE) 27th annual scientific sessions, held during June 2016 in Seattle (WA, USA).
“HCM is the most common inherited cardiac condition, with several disabling and life-threatening complications. Global longitudinal strain was able to independently predict key outcomes in HCM, and therefore has the potential to become an essential tool in HCM risk assessment,” said lead author and study presenter Hongyun Liu, MD, of the JHU HCM Center of Excellence.
HCM is a primary disease of the myocardium in which a portion of it becomes hypertrophic without any obvious cause, creating functional impairment of the cardiac muscle. It is a leading cause of SCD in young athletes, and indeed in any age group, and a cause of disabling cardiac symptoms. HCM is frequently asymptomatic until SCD, and for this reason some suggest routinely screening certain populations for this disease, as the prevalence is about 0.2% to 0.5% of the general population.
Related Links:
Johns Hopkins University
Researchers at Johns Hopkins University (JHU, Baltimore, MD, USA) conducted a study in 400 HCM patients who were followed for 37 months, and who underwent both conventional and strain echocardiography to obtain global longitudinal strain (GLS) data, an objective and reproducible imaging modality than can be used to quantify subtle disturbances in left ventricular (LV) function by detecting sub-endocardial contractility and viability, which often precede an overt impairment of LV function, as measured by ejection fraction (EF).
The results showed that GLS measured by strain echocardiography can be used as a cardiovascular diagnostic technique that is a sensitive and powerful way to assess patient HCM outcomes, which are a common, but often undetected, leading cause of sudden cardiac death (SCD) in young adults. The study was presented as a poster session at the American Society of Echocardiography (ASE) 27th annual scientific sessions, held during June 2016 in Seattle (WA, USA).
“HCM is the most common inherited cardiac condition, with several disabling and life-threatening complications. Global longitudinal strain was able to independently predict key outcomes in HCM, and therefore has the potential to become an essential tool in HCM risk assessment,” said lead author and study presenter Hongyun Liu, MD, of the JHU HCM Center of Excellence.
HCM is a primary disease of the myocardium in which a portion of it becomes hypertrophic without any obvious cause, creating functional impairment of the cardiac muscle. It is a leading cause of SCD in young athletes, and indeed in any age group, and a cause of disabling cardiac symptoms. HCM is frequently asymptomatic until SCD, and for this reason some suggest routinely screening certain populations for this disease, as the prevalence is about 0.2% to 0.5% of the general population.
Related Links:
Johns Hopkins University
Latest Radiography News
- Novel Breast Imaging System Proves As Effective As Mammography
- AI Assistance Improves Breast-Cancer Screening by Reducing False Positives
- AI Could Boost Clinical Adoption of Chest DDR
- 3D Mammography Almost Halves Breast Cancer Incidence between Two Screening Tests
- AI Model Predicts 5-Year Breast Cancer Risk from Mammograms
- Deep Learning Framework Detects Fractures in X-Ray Images With 99% Accuracy
- Direct AI-Based Medical X-Ray Imaging System a Paradigm-Shift from Conventional DR and CT
- Chest X-Ray AI Solution Automatically Identifies, Categorizes and Highlights Suspicious Areas
- AI Diagnoses Wrist Fractures As Well As Radiologists
- Annual Mammography Beginning At 40 Cuts Breast Cancer Mortality By 42%
- 3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery
- Novel AI Technology to Revolutionize Cancer Detection in Dense Breasts
- AI Solution Provides Radiologists with 'Second Pair' Of Eyes to Detect Breast Cancers
- AI Helps General Radiologists Achieve Specialist-Level Performance in Interpreting Mammograms
- Novel Imaging Technique Could Transform Breast Cancer Detection
- Computer Program Combines AI and Heat-Imaging Technology for Early Breast Cancer Detection